Regeneron· @Regeneron · X·· 9 天前精选AI 评分67
AI 导读
再生元在AASLD2026上公布其用于代谢功能障碍相关脂肪性肝病(MASLD)的在研siRNA疗法的积极结果,相关结果同时由NEJM发表。原文未披露具体疗效数据与药物名称,更多信息见链接 https://bit.ly/4ixUodu。
推荐理由
再生元公布其siRNA疗法在MASLD的积极结果并同步发表于NEJM,读者可据此了解该在研疗法的临床数据与发表层级。
正文
We presented positive results for our investigational siRNA therapeutic in metabolic dysfunction-associated steatotic liver disease (#MASLD) at #AASLD2026 that were also published by @NEJM.
Learn more: https://bit.ly/4ixUodu
来源:Regeneron · x.com